The U.S. Food and Drug Administration has approved BridgeBio's drug for a rare and deadly heart condition, the company said ...

Motorists are required to tell the DVLA about any medical conditions that could affect their driving or they could face a ...

The approval of Attruby for transthyretin amyloidosis with cardiomyopathy begins a battle for control of a lucrative market ...

Monash University drug discovery researchers have found that a natural fat molecule called ‘lipoxin A4’ (LXA4) could significantly reduce inflammation and improve function for diabetic hearts.

A group of Abbott HeartMates gathered in Buffalo to meet Damar Hamlin and build community around heart health during the ...